Christopher McBurney

Christopher McBurney is a highly experienced professional with a strong background in the pharmaceutical industry, primarily associated with Novartis.

He holds a Pharm D degree in Pharmacy from the University of Toledo and has furthered his studies by attending the Fellowship School of Public Health at the University of Michigan.

With an extensive career at Novartis, Christopher McBurney has served in various key roles, highlighting his expertise and versatility within the organization.

His positions at Novartis include Vice President, Head US CAR-T Franchise, Head US Oncology Commercial Strategy and Operations, Vice President Sales in Breast Cancer, and Executive Business Director in the U.S. Hematology East Region.

Christopher McBurney's career progression at Novartis also involved roles such as National Scientific Director for MSLs, Head of Professional Strategies and Business Development, US Oncology Marketing Director for Afinitor in Renal Cell Carcinoma & Life Cycle Management, and US Hematology Marketing for Exjade.

Prior to his time at Novartis, he worked as a Fellow at Pfizer (Parke-Davis), showcasing his commitment to enhancing his skills and knowledge in the pharmaceutical field.

Christopher McBurney's background demonstrates a strong focus on oncology, hematology, marketing, sales, pricing, and health economics, showcasing his comprehensive understanding of various facets of the pharmaceutical business.

His education and vast experience within Novartis make him a valuable asset to the pharmaceutical industry, with a proven track record of leadership and strategic management.